120 related articles for article (PubMed ID: 3947276)
1. Cerebrospinal fluid carcinoembryonic antigen in patients with metastatic and nonmetastatic neurological diseases.
Twijnstra A; Nooyen WJ; van Zanten AP; Hart AA; Ongerboer de Visser BW
Arch Neurol; 1986 Mar; 43(3):269-72. PubMed ID: 3947276
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid biochemical markers of central nervous system metastases.
Schold SC; Wasserstrom WR; Fleisher M; Schwartz MK; Posner JB
Ann Neurol; 1980 Dec; 8(6):597-604. PubMed ID: 7212647
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid carcinoembryonic antigen and alphafetoprotein in patients with central nervous system neoplasia.
Rombos A; Evangelopoulu-Katsiri E; Mariatos P; Katsouyanni K; Papagegorgiou C
Acta Neurol Scand; 1988 Jun; 77(6):440-4. PubMed ID: 2457289
[TBL] [Abstract][Full Text] [Related]
4. Carcinoembryonic antigen estimation in cerebrospinal fluid in patients with metastatic breast cancer.
Dearnaley DP; Patel S; Powles TJ; Coombes RC
Oncodev Biol Med; 1981; 2(4):305-11. PubMed ID: 7301610
[TBL] [Abstract][Full Text] [Related]
5. Carcinoembryonic antigen in cerebrospinal fluid of adult brain-tumor patients.
Hill S; Martin E; Ellison EC; Hunt WE
J Neurosurg; 1980 Nov; 53(5):627-32. PubMed ID: 7431072
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid and serum carcinoembryonic antigen in brain tumors.
Batabyal SK; Ghosh B; Sengupta S; Ghosh SN; Chatterjee R
Neoplasma; 2003; 50(5):377-9. PubMed ID: 14628092
[TBL] [Abstract][Full Text] [Related]
7. The clinical relevance of locally produced carcinoembryonic antigen in cerebrospinal fluid.
Jacobi C; Reiber H; Felgenhauer K
J Neurol; 1986 Nov; 233(6):358-61. PubMed ID: 3806144
[TBL] [Abstract][Full Text] [Related]
8. Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis and brain tumors.
Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
J Neurooncol; 1992 Feb; 12(2):111-20. PubMed ID: 1560255
[TBL] [Abstract][Full Text] [Related]
9. Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors.
Twijnstra A; Ongerboer de Visser BW; van Zanten AP; Hart AA; Nooyen WJ
J Neurooncol; 1989 May; 7(1):57-63. PubMed ID: 2666594
[TBL] [Abstract][Full Text] [Related]
10. Baseline serum/cerebrospinal fluid ratio of carcinoembryonic antigen and carbohydrate antigen series biomarkers in non-neoplastic diseases: a cross-sectional study on 224 patients.
Zhang Y; Ban R; Shi Q; Tian C
Clin Biochem; 2019 Jan; 63():135-138. PubMed ID: 30403967
[TBL] [Abstract][Full Text] [Related]
11. Elevation of carcinoembryonic antigen in cerebrospinal fluid among patients with meningeal carcinomatosis.
Klee GG; Tallman RD; Goellner JR; Yanagihara T
Mayo Clin Proc; 1986 Jan; 61(1):9-13. PubMed ID: 3510343
[TBL] [Abstract][Full Text] [Related]
12. Lactic dehydrogenase isoenzymes in the cerebrospinal fluid of patients with systemic cancer.
Fleisher M; Wasserstrom WR; Schold SC; Schwartz MK; Posner JB
Cancer; 1981 Jun; 47(11):2654-9. PubMed ID: 7260857
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen in patients with intracranial tumors.
Suzuki Y; Tanaka R
J Neurosurg; 1980 Sep; 53(3):355-60. PubMed ID: 7420150
[TBL] [Abstract][Full Text] [Related]
14. Sensitive quantitation of carcinoembryonic antigen in cerebrospinal fluid and its barrier-dependent differentiation.
Reiber H; Jacobi C; Felgenhauer K
Clin Chim Acta; 1986 May; 156(3):259-69. PubMed ID: 3521950
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Cerebrospinal Fluid and Serum CEA Concentration in Non-neoplastic Diseases.
Shi Q; Tian C; Huang X; Pu C
Ann Clin Lab Sci; 2016; 46(2):180-3. PubMed ID: 27098625
[TBL] [Abstract][Full Text] [Related]
16. [Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis].
Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
No Shinkei Geka; 1991 Dec; 19(12):1135-41. PubMed ID: 1766538
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical demonstration of carcinoembryonic antigen in cerebrospinal fluid with carcinomatous meningitis from rectal cancer.
Kobayashi TK; Yamaki T; Yoshino E; Higuchi T; Kamachi M
Acta Cytol; 1984; 28(4):430-4. PubMed ID: 6380184
[TBL] [Abstract][Full Text] [Related]
18. Tissue polypeptide antigen activity in cerebrospinal fluid: a marker of central nervous system metastases of breast cancer.
Bach F; Soletormos G; Dombernowsky P
J Natl Cancer Inst; 1991 Jun; 83(11):779-84. PubMed ID: 2041052
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity and specificity of single and combined tumour markers in the diagnosis of leptomeningeal metastasis from breast cancer.
Twijnstra A; van Zanten AP; Nooyen WJ; Ongerboer de Visser BW
J Neurol Neurosurg Psychiatry; 1986 Nov; 49(11):1246-50. PubMed ID: 3540216
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen in patients with untreated central nervous system tumors.
Kido DK; Dyce BJ; Haverback BJ; Rumbaugh CL
Bull Los Angeles Neurol Soc; 1976 Apr; 41(2):47-54. PubMed ID: 1030651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
